Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TP53 | P04637 | 3/20 | 0.47 |
| ▸ | MAPT | P10636 | 3/20 | 0.47 |
| ▸ | POLB | P06746 | 1/20 | 0.41 |
| ▸ | PSEN1 | P49768 | 2/20 | 0.40 |
| ▸ | PSEN2 | P49810 | 2/20 | 0.40 |
| ▸ | APH1B | Q8WW43 | 2/20 | 0.40 |
| ▸ | NCSTN | Q92542 | 2/20 | 0.40 |
| ▸ | APH1A | Q96BI3 | 2/20 | 0.40 |
| ▸ | PSENEN | Q9NZ42 | 2/20 | 0.40 |
| ▸ | RAB9A | P51151 | 1/20 | 0.39 |
| ▸ | HTR7 | P34969 | 1/20 | 0.39 |
| ▸ | PAX8 | Q06710 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4534376 | 0.90 | PSEN1 (0.40) | PSEN1PSEN2APH1BNCSTNAPH1A | |
| SCHEMBL4537228 | 0.89 | POLB (0.41) | POLBPSEN1PSEN2APH1BNCSTN | |
| SCHEMBL4542327 | 0.87 | DRD2 (0.50) | POLBRAB9A | |
| SCHEMBL4530295 | 0.86 | POLB (0.44) | POLBRAB9A | |
| SCHEMBL4542597 | 0.86 | MAPT (0.45) | MAPTPSEN1PSEN2APH1BNCSTN | |
| SCHEMBL4535937 | 0.85 | PSEN1 (0.58) | MAPTPSEN1PSEN2APH1BNCSTN | |
| SCHEMBL4538143 | 0.83 | RAB9A (0.50) | PSEN1PSEN2APH1BNCSTNAPH1A | |
| SCHEMBL4531367 | 0.83 | RAB9A (0.43) | TP53RAB9A | |
| SCHEMBL4542906 | 0.83 | TP53 (0.43) | TP53MAPTPOLBPSEN1PSEN2 | |
| SCHEMBL4541044 | 0.83 | CNR1 (0.45) | PSEN1PSEN2APH1BNCSTNAPH1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2009070497-A1 | SEH AND 11 β-HSD1 INHIBITORS AND THEIR USE | SMITHKLINE BEECHAM CORPORATION (US) | 2009-06-04 | — | — | WO | disclosed |